Today's Market Focus: Two Harbors, Orexigen, Dean Foods, Netflix, Affymax, and Avon Products

Jul 16, 2012, 08:45 ET from

VANCOUVER, British Columbia, July 16, 2012 /PRNewswire-Asia/ -- (PSI) has issued insider trading reports and Equity Research for the following companies: Two Harbors (NYSE: TWO), Orexigen (NASDAQ: OREX), Dean Foods (NYSE: DF), Netflix (NASDAQ: NFLX), Affymax (NASDAQ: AFFY), and Avon Products (NYSE: AVP).

(Logo: )

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

Two Harbors Investment Corporation (NYSE: TWO): Shares of Two Harbors Investment Corporation (NYSE: TWO) started low on Friday but gained 0.28% to US$10.75 at close. Abnormal trading volume of Two Harbors was found reaching 43.52 million shares, 12.8 times heavier than usual day trading. The company announced it priced a public offering of 50 million common stock shares at US$10.44 per share, with total gross proceeds of about US$522 million. Two Harbors gave the underwriters a 30-day window to purchase another 7.5 million shares of its common stock, which would be used to cover overallotments if they arise. This offer will likely expire on July 18, 2012. The net proceeds are expected to be used to buy up more residential mortgage-supported securities, residential mortgage loans and residential properties, as well as properties used for general corporate purposes. The announcement came after an earlier statement by the company that said it planned to offer only 35 million shares of stock. In the last three months, company insiders have purchased a total of US$337,060 through insider buys, with shares ranging from US$10.05 to US$10.28. Are you interested in the non-public stock trading behaviors of Two Harbors insiders? Investors can get the information they need by clicking the following link.

Read Full Report:

Orexigen Therapeutics, Inc. (NASDAQ: OREX): Orexigen Therapeutics, Inc. (NASDAQ: OREX) shares soared 6.81% to US$7.06 and made a new 52-week high of US$7.36. Its price, as of the latest close, was up 479% compared with the 52-week low and was 4% below the 52-week high. There were 13.04 million stock shares traded, which was 3 times more than average volume. Orexigen Therapeutics is a biopharmaceutical company, with market capitalization of US$478.51 million. Do you want to know when Orexigen Therapeutics insiders will buy their shares?

Read Full Report:

Dean Foods Company (NYSE: DF): As a drought in the U.S. Midwest increases the cost of animal feed, U.S. Department of Agriculture recently lowered its production estimate for raw milk and raised its price forecast. In the last trading session, Dean Foods Company (NYSE: DF), a leading U.S. dairy processor, slumped US$0.26 (or -1.76%) at US$14.52 with more than 8.02 million shares exchanged hands for the session compared to its average volume of 3.80 million shares. For the first quarter of 2012, the company reported a net income of US$37.9 million, or 20 cents per share, compared with a net income of US$25.3 million, or 14 cents per share, a year ago. Where do you think Dean Foods will go from here? Academic studies clarify that professional investors can get benefit from insider trading data. Do you want to trace Dean Foods Company on an on-going basis?

Read Full Report:

Today also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.

Netflix, Inc. (NASDAQ: NFLX):

Read Full Report:

Affymax, Inc. (NASDAQ: AFFY):

Read Full Report:

Avon Products, Inc. (NYSE: AVP):

Read Full Report:

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:

Please visit for details.